The present disclosure relates to an inserter device for inserting a medical device subcutaneously comprising an outer part, a housing, and a functional part.
An inserter device also called inserter or injector is commonly used in the medical field for inserting medical devices, such as infusion sets, sensors or the like, through the skin of a patient in a more or less automated fashion.
Commonly, when using an inserter, the user, i.e. the patient or the treatment provider e.g. nurse, doctor, relative, or the like has to apply a force towards the surface of the skin of the patient in order to provide injection of the medical device or a part of the medical device having the form of a needle, a cannula, a sensor, or the like. This can cause physiological or psychological distress and/or discomfort, and may lead to inappropriate application of the medical device. Many people are afraid of sharp objects, such as injection needles and other penetrating devices, commonly used for medical treatment and therapy. This fear is often irrational, and it may hamper an appropriate medical treatment. For example in the case of self-medication, a lack of administration of an appropriate dose of a required medical composition can lead to complications, which may even be life-threatening. When treating diabetes, e.g. in juveniles, there is a risk that the required insulin-dose may not be self-administered due to irrational fear of the insertion needle, combined with a general lack of knowledge and awareness concerning the consequences of omitting the correct application of the device and dosage.
A further known issue with insertion of medical devices is the risk of contamination of the penetrating member before or during application. This can easily lead to the introduction of an infection to a patient, e.g. through a contaminated insertion needle. The longer such a needle is exposed, the higher the risk of accidental contamination, e.g. by touching the needle with a finger, bringing the needle in contact with an unclean surface, or by airborne contamination, aerosol contamination and the like. Depending on the nature of the contamination (e.g. comprising virus, bacteria, fungus, yeast and/or prion) combined with the general health status of the patient, the resulting infection can rapidly turn into a life threatening situation.
Finally, it is well known that contact with an infected, used needle especially in hospital environments can be life-threatening, and the risk of accidental exposure to contaminated material in the form of a used insertion needle must be minimized.
Thus, there is an obvious need in the art for a robust, reliable, accurate, safe, hygienic, and user friendly inserter device, which addresses the issues discussed above.
Disclosed herein is an inserter device for subcutaneously inserting a medical device, the inserter device comprising an outer part comprising one or more locking elements including a first locking element and one or more release elements including a first release element; a housing; and a functional part accommodated in the housing; wherein the housing comprises a sidewall with an inner surface forming a cavity, the housing extending from a first end to a second end along a first axis and comprising one or more housing guide members including a first housing guide member for engagement with one or more guide members of the functional part, and where the housing is at least partly covered by the outer part; wherein the functional part comprises a first part with a first body extending from a first end to a second en along the first axis, the first part comprising one or more first locking members; a second part releasably connected to the first part and comprising a second body extending from a first end to a second end along the first axis, the second part comprising a second guide member and one or more second locking members; an insertion needle attached to the second part; an insertion spring adapted for moving the first part from a first position to a second position in an insertion direction along the first axis in relation to the housing; and a retraction spring adapted for moving the second part from the second position to a third position in an extraction direction along the first axis in relation to the housing; wherein the first housing guide member and the second guide member are configured for rotating the second part about the first axis when the first part is moved from the first position to the second position, whereby the second part is moved from a locked position to an unlocked position relative to the first part.
By guide member/element is meant a protrusion a recess, channel and/or slit. By locked position is meant a position wherein the second part is prevented from moving relative to the first part in the direction of retraction and by an unlocked position is meant a position wherein the second part can move relative to the first part in the direction of retraction, thus away from the first part.
The rotating of the second part such that it is moved from a locked position to an unlocked position relative to the first part provides a simplified inserter device constituting a minimum of separate parts. This is advantageous in relation to production costs.
Other embodiments and advantages are provided below in the detailed description, in the claims and in the drawings.
An embodiment of the inserter device is displayed in the figures, wherein:
The inserter device 100 is displayed in
The inserter part 100 is shown with a port site 104 being an infusion device attached, but other port sites could also be used.
Throughout the description ‘distal’ will refer to the end/surface/element furthest away from the port site 104 and ‘proximal’ will refer to the end/surface/element closest to the port site 104. The ‘vertical’ plane/direction will refer to the plane/direction extending parallel with the insertion needle 102 and the ‘horizontal’ plane/direction will refer to the plane/direction parallel with the patients skin surface, thus perpendicular to the vertical plane/direction.
The housing 200 constitutes an elongated tube comprising a sidewall 203 with an inner surface forming a cavity. The housing 200 has in an oval shape ensuring that the first part 400 cannot rotate in the horizontal plane before, during or after activation of the insertion device 100.
The housing 200 comprises two proximal protrusions 202, which are positioned opposite one another at the distal end 205 of the housing 200. The proximal protrusions 202 are adapted for engaging with two corresponding openings 304 in the outer part 300. The housing 200 further comprises two openings 204, which are positioned horizontally opposite one another approximately in the middle of the housing 200. The openings 204 are adapted for engaging with locking elements 312 on the outer part 300. The proximal protrusions 202 and the openings 204 are aligned pair wise along vertical axes extending from the proximal end 203 to the distal end 205, thus extending in a direction parallel to the direction of insertion.
On the inside of the housing 200, there is a housing guide member 206 extending from proximal end 203 and to approximately the middle of the housing 200. The housing guide member 206 extends along an axis parallel to the axis defined by the pair wise proximal protrusions 202 and openings 204 displaced approximately 80-110 degrees in relation thereto. The housing guide member 206 is adapted for engaging inside a slit 412 in the first part 400, and is dimensioned such that when it engages inside the slit 412, part of it extends through the slit 412 and inside into the inside of the first part 400.
The first section 302 comprises two openings 304 at the distal end 306 of the first section 302. The two openings 304 are adapted for engaging with the corresponding proximal protrusions 202 of the housing 200, thereby interlocking the housing 200 and the outer part 300. On the inside of the distal end 306 there is a protruding annular collar 314 where around the distal end of the insertion spring 402 is positioned. This ensures that the insertion spring 402 cannot be displaced horizontally before, during and/or after insertion and/or retraction of the insertion needle 102.
The second section 303 comprises two outwardly extending arms 307, an engaging device 310, release elements 308, and locking elements 312. The extending arms 307 are positioned opposite one another in the horizontal plane and are directly attached to the first section 302 at their distal end. The engaging device 310 is in this embodiment a ring, which can be either circular or oval. Other shapes could also be imagined. The release elements 308 extend partly on the outwardly extending arms 307 and partly on the engaging device 310.
The locking elements 312 are in this embodiment two inwardly pointing parts for engaging with the openings 204 in the housing 200. The locking elements 312 are positioned opposite one another on the engaging device 310 and are displaced approximately 90 degrees in relation to the release elements 308 and the arms 303. The locking elements 312 ensures that the insertion spring 402 stays in a pre-loaded position before activation of the inserter device 100 by engaging with locking members 410 on the first part 400, thereby fixing the first part 400 at the top of the distal end 205 of the housing 200, thus at a position on top of the locking elements 312.
The first part 400 constitutes a tube comprising a first section 404 and a second section 408, where the outer diameter of the first section 404 is smaller than the outer diameter of the second section 408, thereby forming a support surface 403, whereupon the insertion spring 402 rests at one end.
The first section 404 comprises two releasing slits 406 for engaging with corresponding locking members 508, 508′ on the second part 500. The releasing slits 406 extends from the distal end 401 to the distal surface 407 of the proximal end 409 along a vertical axis parallel to the insertion direction. The first section 404 further comprises a recess 405 on the inner surface facilitating space for an inclining guide member 510 on the second part 500.
The second section 408 has locking members 410 (in this embodiment two protrusions) placed opposite one another in the horizontal plane on the outside of the second section 408. In the pre-loaded shelf position shown in
The proximal surface 414 of the first part 400 is provided with a central annular opening 416 (see
On the inside of the second section 408 are found openings 418 for engaging with corresponding locking members 508, 508′ on the second part 500. In the shelf and the insertion position, the locking members 508, 508′ on the second part 500 are supported by a support rim 419, thereby fixing the retraction spring 502 and the second part 500 in the pre-loaded state. On the distal surface 422 of the proximal end 421 is an annular recess 420 (see
Upon insertion of the insertion needle 102, the proximal surface 414 exercise a pressure on the subcutaneous part 106 locking the subcutaneous body part 110 inside the opening of the port site 104. Further, as the first part 400 after insertion of the insertion needle 102 is pressing against the distal surface 114 of the subcutaneous part 106 due to the relaxed insertion spring 402, the proximal surface 414 assists in releasing the subcutaneous part 106 from the insertion needle 102 as the insertion needle 102 is extracted into the inserter device 100.
Optionally, the first part 400 can be provided with additional means (not shown in the figure) for releasing the subcutaneous part 106 from the insertion needle 102. These means for releasing the subcutaneous part 106 can have the form of a distance piece, which assures that the subcutaneous part 106 is pushed down into the opening of the base 104 with such a force that the subcutaneous part 106 can get past or get in contact with a locking mechanism inside the opening of the base 104. In one embodiment, the means for releasing the subcutaneous part 106 comprises a flat spring placed between the proximal surface 414 of the first part 400 and the distal surface 114 of the subcutaneous part 106. The flat spring is attached to or is a part of the first part 400 at one end. As the first part 400 is pushed down towards the base 104 by the insertion spring 402, the flat spring will be loaded as the first part 400 gets close enough to the base 104. The flat spring will then exercise a pressure on the subcutaneous part 106 locking the subcutaneous body part 100 inside the opening of the base 104.
On the outside of the first section 504 are locking members 508, 508′ (in this embodiment two protrusions) which slide inside the corresponding releasing slits 406 in the first part 400 during activation of the inserter device 100. In between the locking members 508, 508′ is the inclining guide member 510. The second part 500 further comprises recesses 512 for guiding the second part 500 in position inside the first part 400 during manufacturing of the inserter device 100. The insertion needle 102 is attached to the second part 500 and extends up inside the normally solid second part 500.
The position of the second part 500 inside the first part 400 is only an embodiment of the invention. The reverse could also be imagined.
In
Normally, the four parts constituting the inserter device 100, i.e. the housing 200, the outer part 300, the first part 400, and the second part 500, are constructed from a hard plastic possibly combined with sections of a softer material preventing the parts from breaking during activation of the inserter device 100. The insertion spring 402 and the retraction spring 502 are normally metal springs, but other types of materials such as e.g. plastic could also be used.
The pre-loading of the two springs 402, 502 in the shelf state ensures an advantageous compact design of the inserter device 100.
Insertion of the subcutaneous part 106 into a patients skin 112 is done by placing the inserter device 100 on the patients skin 112 with the port site 104 positioned directly on top of the patients skin 112, and then activating the inserter device 100. Normally, a protective release paper has to be removed from the port site 104 prior to placing it on the patients skin 112, thereby exposing an adhesive layer underneath the port site 104 for fastening the port site 104 to the patients skin 112.
Activation of the inserter device 100 is done by applying a pressure on the two release elements 308 on the outer part 300, i.e. deforming the engaging device 310 by pressing the two release elements 308 closer together. The distance between the locking elements 312 thereby increases such that there is enough space to allow for the locking members 410 on the first part 400 to pass by the locking elements 312 at the aid of the insertion spring 402, the latter which in this manner is allowed to relax.
When the insertion spring 402 relaxes, the first part 400 containing the second part 500 and the inserter needle 102 is pressed towards the port site 104, thereby inserting the cannula 108 in the patients skin 112. As the first part 400 progress towards the port site 104, the housing guide member 206 travels inside the slit 412 of the first part 400. Behind the slit 412, the inclining guide member 510 on the second part 500 is positioned, and as the inner housing guide member 206 extending into the first part 400 progresses inside the slit 412, the inner wall 412 comes in contact with the inclining guide member 510 forcing the second part 500 to rotate in a clock-wise direction in the horizontal plane. As a consequence, the locking members 508, 508′ on the second part 500 are released from the inner openings 418 of the first part 400 and the second part 500 is pushed in a direction away from the port site 104 by the aid of the retraction spring 502, the latter which in this manner relaxes.
The interaction between the second part 500 and the first part 400 resulting in the release of the second part 500 from the first part 400 after the insertion of the cannula 108 in the patients skin 112 is illustrated in
In
The clock-wise turning of the second part 500 prompt by the housing guide member 206 progressing inside the slit 412 and turning the inclining guide member 510 is observable when comparing
The second part 500 is normally turned 10-40 degrees in relation to the first part upon release of the second part 500 form the first part 400.
The inserter device 100 is constructed such that it can only be used once, since it is impossible to re-load the springs 402, 502 after activation of the inserter device 100. This is advantageous as the user cannot be tempted to use the device more than once and thereby expose him/her self to an unnecessary health risk.
Construction of the inserter device 100 from essentially four interconnected parts 200, 300, 400, 500 combined with two springs 402, 502 and an insertion needle 102 allows for a simple construction, whereby a rather compacted device is obtained. This reduces production costs.
Normally, the inserter device 100 is contained in a protective bag during transportation. The conditions inside the bag are sterile ensuring that the inserter device 100 can be kept sterile up until the time where it is going to be used.
The only time, the inserter needle 102 is exposes is in the brief moment of insertion. This makes the inserter device 100 safe to handle as the user cannot get in contact with the insertion needle 100 prior to activation of the device and/or after the automatic retraction of the insertion needle 100. It is thereby safe to dispose the inserter device 100 along with ordinary household waster without protecting it before hand.
The automatic insertion and automatic retraction of an insertion needle 102, prompt by applying a pressure in the horizontal plane, is easy to perform by the user, since it essentially involves one action. Further, as the insertion process does not involve applying a pressure in the direction towards to skin, the procedure is more appealing to users, that have a fear of injection needles and other penetrating devices, as these user often find it significantly more difficult to insert an insertion needle if they have to apply a pressure towards the skin at the same time.
This application is the National Stage entry of International Application No. PCT/EP2012/055803 filed Mar. 30, 2012, which claims priority to U.S. Provisional Application No. 61/469,406 filed Mar. 30, 2011, both of which are incorporated herein by reference in their entireties.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP2012/055803 | 3/30/2012 | WO | 00 | 2/5/2016 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2012/131044 | 10/4/2012 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
20040064096 | Flaherty et al. | Apr 2004 | A1 |
20100030155 | Gyrn | Feb 2010 | A1 |
20120094214 | Zahid et al. | Apr 2012 | A1 |
Number | Date | Country |
---|---|---|
WO 2004011065 | Feb 2004 | WO |
WO 2008029280 | Mar 2008 | WO |
WO 2012131044 | Oct 2012 | WO |
Entry |
---|
PCT/EP2012/055803 International Preliminary Report on Patentability dated Oct. 1, 2012. |
PCT/EP2012/055803 Written Opinion completed May 23, 2012. |
PCT/EP2012/055803 International Search Report completed May 23, 2012. |
Number | Date | Country | |
---|---|---|---|
20160243302 A1 | Aug 2016 | US |
Number | Date | Country | |
---|---|---|---|
61469406 | Mar 2011 | US |